Target intelligence / Profile preview

Gamma-aminobutyric acid receptor subunit beta-3 homopentamer (GABRB3 homopentamer)

Target
GABRB3 homopentamer
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor
01

Overview

The Gamma-aminobutyric acid receptor subunit beta-3 (GABRB3) homopentamer is a homomeric ligand-gated ion channel composed of five identical beta-3 subunits. While most native GABAA receptors are heteromeric complexes typically containing alpha, beta, and gamma subunits, the beta-3 subunit is unique in its ability to form functional homopentameric channels that can reach the cell surface. These homopentamers are characteristically insensitive to the neurotransmitter GABA but can be directly activated by other physiological and pharmacological ligands, such as protons, histamine, and general anesthetics like propofol and etomidate. This distinct pharmacological profile makes the beta-3 homopentamer a significant model for structural biology and a potential target for therapeutic intervention in conditions involving pH changes, such as ischemia. The GABRB3 subunit plays a vital role in the development and maintenance of inhibitory signaling within the central nervous system. Genetic variations, including mutations and deletions in the 15q11-q13 chromosomal region where the GABRB3 gene is located, are strongly linked to neurodevelopmental disorders such as Angelman syndrome, autism spectrum disorder, and epilepsy. Drugs that interact with this receptor typically function as positive allosteric modulators or direct agonists, enhancing chloride conductance to reduce neuronal excitability.

Other names
GABRB3 homomerHomomeric beta-3 GABAA receptorGABRB3 pentamerBeta-3 homopentameric GABAA receptorGABAA receptor beta-3 homopentamerGABAA receptor beta3-containing homopentamer
02

Mechanism of action

Direct activation of the chloride channel by protons or anesthetics, and positive allosteric modulation of the channel's open probability.

03

Biological functions

Inhibitory neurotransmissionChloride ion transportProton-gated ion channel activityMaintenance of intracellular chloride homeostasisTonic inhibitionSynaptogenesis
04

Disease associations

EpilepsyAngelman syndromeAutism spectrum disorderInsomniaSchizophrenia
05

Safety considerations

Respiratory depressionExcessive sedationPotential for addiction or abuseDevelopmental neurotoxicity
06

Interacting drugs

Propofol

8 more in the full profile.

07

Biomarkers

GABRB3 gene mutations15q11-q13 chromosomal deletionEEG delta rhythm abnormalities

Beyond the preview

Go deeper on Gamma-aminobutyric acid receptor subunit beta-3 homopentamer (GABRB3 homopentamer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit beta-3 homopentamer (GABRB3 homopentamer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call